6505--Metformin SA Tablets REPACK PROGRAM

The Department of Veterans Affairs National Acquisition Center is seeking suppliers for Metformin HCL Sustained Action (SA) tablets through an unrestricted solicitation targeting pharmaceutical manufacturers. The contract encompasses two distinct groups: Group 1 for Other Government Agencies (including DoD, Indian Health Service, and Bureau of Prisons) and Group 2 for VA facilities, with distribution through VA and DoD Pharmaceutical Prime Vendors. Contractors must maintain current FDA Good Manufacturing Practice compliance and provide unique 11-digit NDC numbers for each product offered. The evaluation will be based on lowest-priced technically acceptable offeror(s), with the potential for awarding one or two separate contracts depending on group performance. Proposals are due January 28, 2025 at 2:30 PM Central Time, with a contract structure featuring a one-year base period and four consecutive one-year option periods.

The solicitation requires Metformin HCL SA tablets in 500mg and 750mg strengths, with specific packaging requirements including safety-cap configurations and precise bottle specifications. For Group 1, tablets will be available in 100, 500, and 1,000 count bottles, while Group 2 will involve bulk quantities starting at 1,000 tablets in the base year and transitioning to 10,000-tablet drums in option years. A mandatory 0.5% Cost Recovery Fee must be incorporated into pricing, and all unit-of-use packaging must meet detailed technical specifications such as cylindrical bottle design and label placement requirements. The contract is categorized under NAICS 325412 for Pharmaceutical Preparation Manufacturing and PSC 6505 for Drugs and Biologicals, indicating a focused pharmaceutical procurement strategy designed to meet comprehensive government healthcare supply needs.